Efficacy of a small molecule inhibitor of the transcriptional cofactor PC4 in prevention and treatment of non-small cell lung cancer.
The human positive coactivator 4 (PC4) was originally identified as a multi-functional cofactor capable of mediating transcription activation by diverse gene- and tissue-specific activators. Recent studies suggest that PC4 might also function as a novel cancer biomarker and therapeutic target for di...
Main Authors: | Yan Zhang, Andrei Pavlov, Sohail Malik, Hong Chen, Nancy Kim, Ziqing Li, Xiaohong Zhang, Melvin L DePamphilis, Robert G Roeder, Hui Ge |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0230670 |
Similar Items
-
How Diverse Are the Protein-Bound Conformations of Small-Molecule Drugs and Cofactors?
by: Nils-Ole Friedrich, et al.
Published: (2018-03-01) -
Cip/Kip cyclin-dependent protein kinase inhibitors and the road to polyploidy
by: DePamphilis Melvin L, et al.
Published: (2009-06-01) -
PIKFYVE inhibitors trigger interleukin‐24‐dependent cell death of autophagy‐dependent melanoma
by: Ajit Roy, et al.
Published: (2024-04-01) -
Compensatory sequence variation between trans-species small RNAs and their target sites
by: Nathan R Johnson, et al.
Published: (2019-12-01) -
Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors
by: Susana Valente, et al.
Published: (2012-11-01)